Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Alkermes (ALKS) Shares Outstanding (Diluted Average) (2020 - 2023)

Alkermes (ALKS) has disclosed Shares Outstanding (Diluted Average) for 8 consecutive years, with $169.7 million as the latest value for Q4 2023.

  • Quarterly Shares Outstanding (Diluted Average) rose 3.66% to $169.7 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $169.7 million through Dec 2023, up 3.66% year-over-year, with the annual reading at $169.7 million for FY2023, 3.66% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2023 was $169.7 million at Alkermes, up from $165.1 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $169.7 million in Q4 2023, with the low at $158.8 million in Q4 2020.
  • Average Shares Outstanding (Diluted Average) over 4 years is $163.7 million, with a median of $163.6 million recorded in 2022.
  • The sharpest move saw Shares Outstanding (Diluted Average) grew 3.75% in 2021, then fell 0.61% in 2022.
  • Over 4 years, Shares Outstanding (Diluted Average) stood at $158.8 million in 2020, then rose by 3.75% to $164.8 million in 2021, then decreased by 0.61% to $163.7 million in 2022, then grew by 3.66% to $169.7 million in 2023.
  • According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods came in at $169.7 million, $165.1 million, and $163.7 million for Q4 2023, Q1 2023, and Q4 2022 respectively.